SCHEMBL24258651

SCHEMBL24258651

COP(=O)(S)OC[C@H]1O[C@@H](n2cnc3c(=O)n4ccnc4[nH]c32)[C@H](OP(=O)(S)OC[C@H]2C[C@@H](n3cnc4c(N)ncnc43)[C@@H]2C)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ RNASEL Q05823 11/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24258653 0.93 NT5E (0.37) RNASEL
SCHEMBL25691489 0.84 P2RY1 (0.43) RNASEL
SCHEMBL24444133 0.84 P2RY1 (0.48) RNASEL
SCHEMBL21263943 0.84 FHIT (0.45) —
SCHEMBL24258639 0.83 P2RY1 (0.43) RNASEL
SCHEMBL24680655 0.81 NT5E (0.40) RNASEL
SCHEMBL21263944 0.80 FHIT (0.40) —
SCHEMBL20908779 0.80 P2RY1 (0.42) RNASEL
SCHEMBL24321956 0.79 FHIT (0.37) RNASEL
SCHEMBL24258659 0.79 ENPP1 (0.41) RNASEL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3752516-B1 CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS BRISTOL MYERS SQUIBB CO (US) 2022-02-23 — — EP disclosed
Send feedback